Beth‐Ann Lesnikoski

729 total citations
14 papers, 372 citations indexed

About

Beth‐Ann Lesnikoski is a scholar working on Cancer Research, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Beth‐Ann Lesnikoski has authored 14 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 6 papers in Surgery and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Beth‐Ann Lesnikoski's work include Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (5 papers) and Breast Implant and Reconstruction (3 papers). Beth‐Ann Lesnikoski is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (5 papers) and Breast Implant and Reconstruction (3 papers). Beth‐Ann Lesnikoski collaborates with scholars based in United States and Sweden. Beth‐Ann Lesnikoski's co-authors include Judy E. Garber, Michael J. Campbell, O. Olopade, Nola M. Hylton, Elisa Port, E. Shelley Hwang, Chris I. Flowers, Elisabeth R. Garwood, Laura J. Esserman and Dan H. Moore and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Beth‐Ann Lesnikoski

12 papers receiving 362 citations

Peers

Beth‐Ann Lesnikoski

SURGE

ONCOL

PRM

PFM

Valeria Sanna Italy

Lamar Eaton United States

Stephen DeSantis United States

Avivit Neumann Israel

Flemming Hansen Denmark

Jinghong Guan China

Harlinde De Schutter Belgium

A. Manzari Italy

Fumine Tsukamoto Japan

Valeria Sanna Italy

Beth‐Ann Lesnikoski

105 ×0.4

118 ×0.7

SURGE

193 ×1.9

ONCOL

65 ×0.7

PRM

44 ×0.5

PFM

Citations per year, relative to Beth‐Ann Lesnikoski Beth‐Ann Lesnikoski (= 1×) peers Valeria Sanna

Countries citing papers authored by Beth‐Ann Lesnikoski

Since Specialization

Citations

This map shows the geographic impact of Beth‐Ann Lesnikoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth‐Ann Lesnikoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth‐Ann Lesnikoski more than expected).

Fields of papers citing papers by Beth‐Ann Lesnikoski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth‐Ann Lesnikoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth‐Ann Lesnikoski. The network helps show where Beth‐Ann Lesnikoski may publish in the future.

Co-authorship network of co-authors of Beth‐Ann Lesnikoski

This figure shows the co-authorship network connecting the top 25 collaborators of Beth‐Ann Lesnikoski. A scholar is included among the top collaborators of Beth‐Ann Lesnikoski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth‐Ann Lesnikoski. Beth‐Ann Lesnikoski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Crozier, Jennifer A., Todd A. Pezzi, Beth‐Ann Lesnikoski, et al.. (2020). Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis. The Lancet Oncology. 21(12). 1611–1619. 45 indexed citations

Lesnikoski, Beth‐Ann, Jennifer A. Crozier, Gordan Srkalović, et al.. (2020). Molecular profiles and treatment recommendations for invasive lobular carcinoma in a real-world prospective breast cancer registry.. Journal of Clinical Oncology. 38(15_suppl). e19291–e19291. 1 indexed citations

Crozier, Jennifer A., Todd A. Pezzi, Beth‐Ann Lesnikoski, et al.. (2020). Abstract P2-14-03: Exploring the benefit of adjuvant chemotherapy in elderly women with triple negative breast cancer: 16,062 women age 70 and above. Cancer Research. 80(4_Supplement). P2–14. 1 indexed citations

Soulos, Pamela R., Jeph Herrin, Kenneth B. Roberts, et al.. (2013). For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery. Surgery. 155(5). 776–788. 7 indexed citations

Soulos, Pamela R., Jeph Herrin, Kenneth B. Roberts, et al.. (2013). For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery.. Journal of Clinical Oncology. 31(15_suppl). 6511–6511.

Presley, Carolyn J., Pamela R. Soulos, Jeph Herrin, et al.. (2012). Patterns of Use and Short-Term Complications of Breast Brachytherapy in the National Medicare Population From 2008–2009. Journal of Clinical Oncology. 30(35). 4302–4307. 53 indexed citations

Presley, Carolyn J., Pamela R. Soulos, Jeph Herrin, et al.. (2012). Short-term complications and use of breast brachytherapy in the national Medicare population in 2008-2009.. Journal of Clinical Oncology. 30(15_suppl). 1030–1030.

Garwood, Elisabeth R., Anjali S. Kumar, Frederick L. Baehner, et al.. (2009). Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Research and Treatment. 119(1). 137–144. 179 indexed citations

Golshan, Mehra, Beth‐Ann Lesnikoski, & Susan C. Lester. (2006). Sentinel Lymph Node Biopsy for Occult Breast Cancer Detected during Breast Reduction Surgery. The American Surgeon. 72(5). 397–400. 12 indexed citations

10.

Jones, Julie, Esther Rhei, Michele A. Gadd, et al.. (2004). Predictive value of sentinel lymph node biopsy prior to neoadjuvant chemotherapy in clinically node negative breast cancer. Journal of Clinical Oncology. 22(14_suppl). 606–606. 2 indexed citations

11.

Partridge, Ann H., Beth‐Ann Lesnikoski, & Harold J. Burstein. (2002). Treatment of breast cancer during pregnancy. Expert Opinion on Pharmacotherapy. 3(4). 423–428. 3 indexed citations

12.

Gibson, G. R., Beth‐Ann Lesnikoski, James Yoo, et al.. (2001). A Comparison of Ink-Directed and Traditional Whole-Cavity Re-Excision for Breast Lumpectomy Specimens With Positive Margins. Annals of Surgical Oncology. 8(9). 693–704. 51 indexed citations

13.

Lesnikoski, Beth‐Ann, et al.. (1997). Thrombin Inhibition in discordant xenograft rejection. Xenotransplantation. 4(3). 140–146. 6 indexed citations

14.

Fh, Bach, Christiane Ferran, Maria T. Millan, et al.. (1995). Xenotransplantation: endothelial cell activation and beyond.. PubMed. 27(1). 77–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact